Published in TB and Outbreaks Week, December 11th, 2001
Specifically, U.S. Patent No. 6,303,302, which has been issued to the Whitehead Institute for Biomedical Research and exclusively licensed to Microbia, includes broad claims to methods of identifying and isolating genes involved in the regulation of fungal gene expression, methods useful for identifying fungal genes that promote infectivity, and methods of identifying agents that regulate the expression or activity of genes required for fungal infection. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.